Nephros, Inc.NEPHNASDAQ
Loading
Year-over-year research & development expense growth
Latest
47.79%
↑ 278% vs avg
Percentile
P86
Within normal range
Streak
2 yr
Consecutive growthAccelerating
Average
12.64%
Historical baseline
| Period | Value |
|---|---|
| 2025 | 47.79% |
| 2024 | 3.78% |
| 2023 | -30.44% |
| 2022 | -16.22% |
| 2021 | -45.70% |
| 2020 | -10.71% |
| 2019 | 100.78% |
| 2018 | 53.59% |
| 2017 | -7.14% |
| 2016 | 30.63% |